BAGSVAERD, DENMARK--(Marketwire - October 05, 2009) - Novo Nordisk A/S - Share repurchase programme
On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.
Since the announcement as of 28 September 2009, the following transactions have been made under the programme:
Number of Average Transaction shares purchase price value, DKK Accumulated, last announcement 2,682,500 853,849,597 28 September 2009 70,000 320.8900 22,462,300 29 September 2009 59,500 321.9410 19,155,490 30 September 2009 75,000 318.8990 23,917,425 1 October 2009 75,000 317.6710 23,825,325 2 October 2009 70,000 319.9301 22,395,107 Accumulated under the programme 3,032,000 965,605,244
With the transactions stated above, Novo Nordisk owns a total of 27,868,808 treasury shares, corresponding to 4.5% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.
Correction:
In the company announcement as of 28 September 2009 related to the share repurchase programme, the dates in the table were not updated properly. All numbers and ownership figures were however correct.
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 28,500 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol ‘NVO’. For more information, visit novonordisk.com.
Further information: Media: Investors: Outside North America: Outside North America: Mette Kruse Danielsen Mads Veggerby Lausten Tel: (+45) 4442 3883 Tel: (+45) 4443 7919 mkd@novonordisk.com mlau@novonordisk.com Kasper Roseeuw Poulsen Tel: 4442 4471 krop@novonordisk.com In North America: In North America: Sean Clements Hans Rommer Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937 secl@novonordisk.com hrmm@novonordisk.com
Company Announcement no 59 / 2009
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
